UCB presents new data at 35th International Epilepsy Congress (IEC) highlighting important advancements across Fintepla®▼(fenfluramine) oral solution and broader epilepsies portfolio
was conducted to examine the efficacy of fenfluramine on GTCS reduction in various types of Developmental and Epileptic Encephalopathies or rare epilepsy conditions. Data from 13 studies , 4.